KIDNEY TRANSPLANT RECIPIENT RESPONSE TO SHINGRIX VACCINE

Clinical trials for KIDNEY TRANSPLANT RECIPIENT RESPONSE TO SHINGRIX VACCINE explained in plain language.

Never miss a new study

Get alerted when new KIDNEY TRANSPLANT RECIPIENT RESPONSE TO SHINGRIX VACCINE trials appear

Sign up with your email to follow new studies for KIDNEY TRANSPLANT RECIPIENT RESPONSE TO SHINGRIX VACCINE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Extra vaccine dose tested to protect vulnerable kidney patients from shingles

⭐️ VACCINE ⭐️ Recruiting now

This study is testing whether an extra dose of the shingles vaccine (Shingrix) provides better protection for people with kidney failure who receive a transplant. Researchers want to see how well the vaccine works and how safe it is in this group, who are at higher risk for shing…

Matched conditions: KIDNEY TRANSPLANT RECIPIENT RESPONSE TO SHINGRIX VACCINE

Phase: PHASE3 • Sponsor: University of Colorado, Denver • Aim: ⭐️ VACCINE ⭐️

Last updated Apr 13, 2026 20:18 UTC

KIDNEY TRANSPLANT RECIPIENT RESPONSE TO SHINGRIX VACCINE

Get alerted when new KIDNEY TRANSPLANT RECIPIENT RESPONSE TO SHINGRIX VACCINE trials appear

Extra vaccine dose tested to protect vulnerable kidney patients from shingles